<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658040"><TermName>Navelbine</TermName><TermPronunciation>(nay-VEL-been)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat advanced non-small cell lung cancer. It blocks cell growth by stopping cell division and may cause cancer cells to die. It is a type of vinca alkaloid and a type of antimitotic agent. Also called vinorelbine tartrate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000725846" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Navelbine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000725847" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Navelbina&quot;" language="es" id="_4"/><SpanishTermName>Navelbina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar el cáncer de pulmón de células pequeñas en estadio avanzado. Bloquea la formación de células al impedir la multiplicación celular y podría destruir las células cancerosas. Es un tipo de alcaloide de vinca y un tipo de antimitótico. También se llama tartrato de vinorelbina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2010-03-01</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000695633">Vinorelbine Tartrate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
